Variant report

Variant	nsv10519
Chromosome Location	chr4:69816500-69835939
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:147)
CpG islands
(count:244)
Chromatin interactive
region (count:0)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:147 , 50 per page) page: 1 2 3

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr4:69819937-69820253	HepG2	liver:	n/a	n/a
2	ARID3A	chr4:69816858-69818218	HepG2	liver:	n/a	n/a
3	ARID3A	chr4:69819154-69819171	HepG2	liver:	n/a	n/a
4	ATF1	chr4:69819917-69820207	K562	blood:	n/a	n/a
5	ATF2	chr4:69816810-69817127	H1-hESC	embryonic stem cell:	n/a	n/a
6	BATF	chr4:69817167-69817565	GM12878	blood:	n/a	chr4:69817539-69817548
7	BCL11A	chr4:69817186-69817521	GM12878	blood:	n/a	n/a
8	BHLHE40	chr4:69817141-69817585	HepG2	liver:	n/a	n/a
9	CEBPB	chr4:69831597-69831751	HepG2	liver:	n/a	chr4:69831648-69831659
10	CEBPB	chr4:69829647-69829949	HepG2	liver:	n/a	chr4:69829802-69829813
11	CEBPB	chr4:69817993-69818138	HepG2	liver:	n/a	chr4:69818070-69818081
12	CEBPB	chr4:69817147-69818247	HepG2	liver:	n/a	chr4:69818070-69818081
13	CEBPB	chr4:69819918-69820108	K562	blood:	n/a	n/a
14	CEBPB	chr4:69817908-69818225	IMR90	lung:	n/a	chr4:69818070-69818081
15	CEBPB	chr4:69817235-69817388	HepG2	liver:	n/a	n/a
16	CEBPD	chr4:69819885-69820292	K562	blood:	n/a	n/a
17	CHD2	chr4:69817279-69817534	HepG2	liver:	n/a	n/a
18	CTCF	chr4:69817460-69817610	HepG2	liver:	n/a	n/a
19	CTCF	chr4:69817320-69817470	HepG2	liver:	n/a	n/a
20	CTCF	chr4:69817309-69817486	GM12878	blood:	n/a	n/a
21	CTCF	chr4:69833956-69833986	Kidney_OC	kidney:	n/a	n/a
22	CTCF	chr4:69826360-69826510	Caco-2	colon:	n/a	n/a
23	CTCF	chr4:69829374-69829423	Fibrobl	skin:	n/a	n/a
24	CTCF	chr4:69816940-69817090	HepG2	liver:	n/a	n/a
25	CUX1	chr4:69826575-69826842	GM12878	blood:	n/a	n/a
26	EBF1	chr4:69817258-69817532	GM12878	blood:	n/a	n/a
27	ELF1	chr4:69817145-69817466	HepG2	liver:	n/a	n/a
28	EP300	chr4:69817085-69817686	HepG2	liver:	n/a	n/a
29	EP300	chr4:69819834-69820212	K562	blood:	n/a	n/a
30	EP300	chr4:69816450-69816600	GM12878	blood:	n/a	n/a
31	EP300	chr4:69817047-69817732	HepG2	liver:	n/a	n/a
32	EP300	chr4:69819817-69820254	HepG2	liver:	n/a	n/a
33	EP300	chr4:69817243-69817641	HepG2	liver:	n/a	n/a
34	EP300	chr4:69817111-69817566	A549	lung:	n/a	n/a
35	FOSL2	chr4:69817152-69817551	HepG2	liver:	n/a	chr4:69817371-69817382
36	FOSL2	chr4:69817180-69817561	HepG2	liver:	n/a	chr4:69817371-69817382
37	FOXA1	chr4:69829095-69829442	A549	lung:	n/a	n/a
38	FOXA1	chr4:69817024-69818124	HepG2	liver:	n/a	n/a
39	FOXA1	chr4:69819932-69820323	HepG2	liver:	n/a	n/a
40	FOXA1	chr4:69817086-69817708	HepG2	liver:	n/a	n/a
41	FOXA1	chr4:69816989-69817615	HepG2	liver:	n/a	n/a
42	FOXA1	chr4:69817120-69817627	HepG2	liver:	n/a	n/a
43	FOXA2	chr4:69817200-69817685	A549	lung:	n/a	n/a
44	FOXA2	chr4:69817139-69817592	HepG2	liver:	n/a	n/a
45	FOXA2	chr4:69819890-69820320	HepG2	liver:	n/a	n/a
46	FOXA2	chr4:69817149-69817573	A549	lung:	n/a	n/a
47	GATA1	chr4:69819752-69820217	PBDE	blood:	n/a	n/a
48	GATA1	chr4:69819753-69820302	K562	blood:	n/a	n/a
49	GATA1	chr4:69818750-69819232	PBDE	blood:	n/a	n/a
50	GATA2	chr4:69819848-69820225	K562	blood:	n/a	n/a

(count:244 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr4:69819820-69819870	ProgFib	skin:	n/a
2	chr4:69829409-69829459	CMK	blood:	n/a
3	chr4:69819820-69819870	HRCEpiC	kidney:	n/a
4	chr4:69829409-69829459	NHDF-neo	bronchial:	n/a
5	chr4:69818856-69818906	HEEpiC	esophagus:	n/a
6	chr4:69818856-69818906	HEK293	kidney:	embryo
7	chr4:69818856-69818906	SAEC	small airway:	n/a
8	chr4:69819820-69819870	AG09319	gingival:	n/a
9	chr4:69819820-69819870	SAEC	small airway:	n/a
10	chr4:69817080-69817130	RPTEC	kidney:	n/a
11	chr4:69829409-69829459	HRE	kidney:	n/a
12	chr4:69829409-69829459	GM12878	blood:	n/a
13	chr4:69829409-69829459	HMEC	breast:	n/a
14	chr4:69818856-69818906	HRCEpiC	kidney:	n/a
15	chr4:69829409-69829459	AG09319	gingival:	n/a
16	chr4:69817080-69817130	MCF-7	breast:	n/a
17	chr4:69819820-69819870	ovcar-3	ovarian:	n/a
18	chr4:69819820-69819870	HIPEpiC	eye:	n/a
19	chr4:69819820-69819870	NH-A	brain:	n/a
20	chr4:69829409-69829459	Caco-2	colon:	n/a
21	chr4:69829409-69829459	BJ	skin:	n/a
22	chr4:69817080-69817130	ECC-1	luminal epithelium:	n/a
23	chr4:69819820-69819870	ECC-1	luminal epithelium:	n/a
24	chr4:69818856-69818906	ovcar-3	ovarian:	n/a
25	chr4:69818856-69818906	U87	brain:	n/a
26	chr4:69829409-69829459	ECC-1	luminal epithelium:	n/a
27	chr4:69829409-69829459	AoSMC	blood vessel:	n/a
28	chr4:69829409-69829459	GM06990	blood:	n/a
29	chr4:69829409-69829459	GM19239	blood:	n/a
30	chr4:69819820-69819870	HNPCEpiC	eye:	n/a
31	chr4:69818856-69818906	PFSK-1	brain:	n/a
32	chr4:69817080-69817130	MCF10A-Er-Src	breast:	n/a
33	chr4:69818856-69818906	NHDF-neo	bronchial:	n/a
34	chr4:69818856-69818906	NT2-D1	testis:	n/a
35	chr4:69818856-69818906	GM19239	blood:	n/a
36	chr4:69829409-69829459	GM12891	blood:	n/a
37	chr4:69818856-69818906	K562	blood:	n/a
38	chr4:69829409-69829459	ProgFib	skin:	n/a
39	chr4:69819820-69819870	HRE	kidney:	n/a
40	chr4:69817080-69817130	IMR90	lung:	fetal
41	chr4:69819820-69819870	NT2-D1	testis:	n/a
42	chr4:69817080-69817130	NHBE	bronchial:	n/a
43	chr4:69817080-69817130	HL-60	blood:	n/a
44	chr4:69817080-69817130	BE2_C	brain:	n/a
45	chr4:69829409-69829459	PrEC	prostate:	n/a
46	chr4:69829409-69829459	MCF10A-Er-Src	breast:	n/a
47	chr4:69817080-69817130	NT2-D1	testis:	n/a
48	chr4:69829409-69829459	SK-N-SH	brain:	n/a
49	chr4:69817080-69817130	HCM	heart:	n/a
50	chr4:69829409-69829459	A549	lung:	n/a

No data

Variant related genes	Relation type
UGT2A3	TF binding region
UGT2A3	CpG island

Extended variants
information (count: 940 )
Associated
traits (count: 83 )

Variant overlapped rSNPs/rCNVs (count:940 , 50 per page) page: 1 2 3 4 5 6 7 ... 19

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs535035161	chr4:69816519-69816520	Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs188677635	chr4:69816536-69816537	Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs35916705	chr4:69816550-69816551	Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs574756160	chr4:69816622-69816623	Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs543430308	chr4:69816624-69816625	Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs556886772	chr4:69816654-69816655	Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs576967893	chr4:69816666-69816667	Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs546277529	chr4:69816674-69816675	Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs150350309	chr4:69816691-69816692	Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs371733530	chr4:69816734-69816735	Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs61588658	chr4:69816745-69816746	Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs375363371	chr4:69816784-69816785	Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs201160636	chr4:69816795-69816796	Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs371911179	chr4:69816797-69816798	Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs372791849	chr4:69816803-69816804	Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs140403131	chr4:69816804-69816805	Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs375056791	chr4:69816809-69816810	Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs369933690	chr4:69816828-69816829	Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs138523993	chr4:69816836-69816837	Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs144099944	chr4:69816844-69816845	Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs150974029	chr4:69816850-69816851	Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs79825415	chr4:69816856-69816857	Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs267600217	chr4:69816861-69816862	Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs373818808	chr4:69816871-69816872	Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs541628105	chr4:69816892-69816893	Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs140786698	chr4:69816893-69816894	Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs375022148	chr4:69816901-69816902	Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs369087528	chr4:69816905-69816906	Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs202059672	chr4:69816906-69816907	Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs561986343	chr4:69816908-69816909	Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs150107106	chr4:69816909-69816910	Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs550604933	chr4:69816922-69816923	Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs267600218	chr4:69816923-69816924	Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs200911703	chr4:69816936-69816937	Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs570452785	chr4:69816941-69816942	Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs144984988	chr4:69816958-69816959	Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs267600219	chr4:69816961-69816962	Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs372964177	chr4:69816966-69816967	Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs377542515	chr4:69816978-69816979	Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs546651597	chr4:69816983-69816984	Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs181458330	chr4:69816986-69816987	Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs148833569	chr4:69817050-69817051	Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs184239988	chr4:69817057-69817058	Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs146928827	chr4:69817058-69817059	Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs139351499	chr4:69817076-69817077	Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs3749510	chr4:69817080-69817081	Enhancers Active TSS Weak transcription Flanking Active TSS	TF binding region CpG island	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
47	rs201266507	chr4:69817081-69817082	Enhancers Active TSS Weak transcription Flanking Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
48	rs113782289	chr4:69817100-69817101	Enhancers Active TSS Weak transcription Flanking Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
49	rs371161380	chr4:69817101-69817102	Enhancers Active TSS Weak transcription Flanking Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
50	rs537304565	chr4:69817110-69817111	Enhancers Active TSS Weak transcription Flanking Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:83)

Disease	PMID	Source
Gastrointestinal stromal cancer	16982739	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Glioblastoma multiforme	21080181	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Chordoma	21602918	CNVD
HIV/AIDS	22032296	CNVD
Medulloblastoma	21979893	CNVD
Neuroblastoma	18923191	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Breast cancer	21858162	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Gastric cancer	21586687	CNVD
lymphocytic leukemia	21291569	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Non-small cell lung cancer	21829676	CNVD
Melanoma	18172304	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Lung cancer	18438408	CNVD
Breast cancer	17603634	CNVD
Glioblastoma multiforme	21922591	CNVD
Parkinson disease	21956041	CNVD
Mental retardation	20522426	CNVD
delayed speech	20522426	CNVD
growth disorder	20522426	CNVD
Hepatocellular carcinoma	16750200	CNVD
Myxofibrosarcoma	16751306	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Parkinson disease	18923514	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Cancer	21183584	CNVD
Breast cancer	16272173	CNVD
Multiple myeloma	16616336	CNVD
Colorectal cancer	19359472	CNVD
Malignant mesothelioma	18160781	CNVD
Medulloblastoma	18056178	CNVD
Multiple myeloma	17077331	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Oral squamous cell carcinoma	17134496	CNVD
4q-syndrome	17576883	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Colorectal cancer	20709793	CNVD
Muscular dystrophy	21149563	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Cervical cancer	21062161	CNVD
Metanephric adenoma	20802469	CNVD
Breast cancer	16608533	CNVD
Colorectal cancer	16272173	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Lung cancer	19208797	CNVD
Wilms tumour	21544195	CNVD
Breast cancer	21785460	CNVD
Acute myeloid leukemia	21251322	CNVD
Prostate cancer	16573809	CNVD
Osteoporosis	18992858	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Myelodysplastic syndrome	21251322	CNVD
Multiple myeloma	17550852	CNVD
Graft versus host disease	20877625	CNVD
Breast cancer	21990379	CNVD
Myelofibrosis	22110671	CNVD
Osteoporosis	20877625	CNVD
Osteoporosis	19737800	CNVD
Congenital anomalies of the kidney and urinary tract	18316590	CNVD
Glioblastoma multiforme	21138945	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
small cell lung cancer	20016488	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:96 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:69808600-69819600	Weak transcription	Small Intestine	intestine
2	chr4:69811600-69817600	Active TSS	Fetal Intestine Large	intestine
3	chr4:69812200-69817800	Active TSS	Duodenum Mucosa	Duodenum
4	chr4:69812600-69817600	Active TSS	Fetal Intestine Small	intestine
5	chr4:69812600-69817600	Active TSS	Rectal Mucosa Donor 29	rectum
6	chr4:69814200-69817400	Active TSS	Fetal Stomach	stomach
7	chr4:69814400-69817400	Active TSS	Rectal Mucosa Donor 31	rectum
8	chr4:69814400-69817600	Active TSS	Fetal Kidney	kidney
9	chr4:69814600-69817200	Active TSS	Pancreatic Islets	Pancreatic Islet
10	chr4:69814600-69817400	Active TSS	Liver	Liver
11	chr4:69814800-69817000	Active TSS	HepG2	liver
12	chr4:69815200-69816800	Weak transcription	Pancreas	Pancrea
13	chr4:69815200-69816800	Weak transcription	Rectal Smooth Muscle	rectum
14	chr4:69815200-69825600	Weak transcription	Sigmoid Colon	Sigmoid Colon
15	chr4:69816400-69817400	Active TSS	Colonic Mucosa	Colon
16	chr4:69816800-69817400	Active TSS	Pancreas	Pancrea
17	chr4:69816800-69817400	Active TSS	Rectal Smooth Muscle	rectum
18	chr4:69816800-69817600	Enhancers	Stomach Mucosa	stomach
19	chr4:69817000-69817200	Flanking Active TSS	HepG2	liver
20	chr4:69817000-69817400	Enhancers	HUES48 Cell Line	embryonic stem cell
21	chr4:69817000-69817400	Enhancers	iPS-20b Cell Line	embryonic stem cell
22	chr4:69817200-69817600	Enhancers	Fetal Heart	heart
23	chr4:69817200-69819800	Enhancers	HepG2	liver
24	chr4:69817400-69817600	Flanking Active TSS	Liver	Liver
25	chr4:69817400-69817600	Flanking Active TSS	Rectal Mucosa Donor 31	rectum
26	chr4:69817400-69819600	Weak transcription	Pancreas	Pancrea
27	chr4:69817600-69818000	Enhancers	Fetal Kidney	kidney
28	chr4:69817600-69818000	Weak transcription	Rectal Mucosa Donor 29	rectum
29	chr4:69817600-69818200	Enhancers	Rectal Mucosa Donor 31	rectum
30	chr4:69817600-69818600	Enhancers	Liver	Liver
31	chr4:69817600-69818600	Weak transcription	Fetal Heart	heart
32	chr4:69817600-69818600	Weak transcription	Stomach Mucosa	stomach
33	chr4:69817600-69820600	Enhancers	Fetal Intestine Large	intestine
34	chr4:69817600-69820600	Enhancers	Fetal Intestine Small	intestine
35	chr4:69817800-69820400	Enhancers	Duodenum Mucosa	Duodenum
36	chr4:69818000-69818200	Enhancers	Rectal Mucosa Donor 29	rectum
37	chr4:69818000-69818600	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
38	chr4:69818200-69818800	Weak transcription	Rectal Mucosa Donor 29	rectum
39	chr4:69818200-69820000	Weak transcription	Rectal Mucosa Donor 31	rectum
40	chr4:69818600-69818800	Flanking Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
41	chr4:69818600-69819800	Weak transcription	Liver	Liver
42	chr4:69818600-69820200	Enhancers	Fetal Heart	heart
43	chr4:69818600-69820200	Enhancers	Stomach Mucosa	stomach
44	chr4:69818800-69819200	Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
45	chr4:69818800-69820200	Enhancers	Rectal Mucosa Donor 29	rectum
46	chr4:69819200-69819400	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
47	chr4:69819400-69819600	Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
48	chr4:69819600-69820200	ZNF genes & repeats	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
49	chr4:69819600-69820200	Enhancers	Pancreas	Pancrea
50	chr4:69819600-69820400	Enhancers	Small Intestine	intestine

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links